We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Cynthia A. Harris
Cynthia A. Harris
Products
PRODUCTS
Erika D. Feller
Cynthia A. Harris
Price:
$117.00
View
Triaid, Inc.
Cynthia A. Harris
Price:
$117.00
View
Best Medical International, Inc.
Cynthia A. Harris
Price:
$117.00
View
BioElectronics Corp.
Cynthia A. Harris
Price:
$117.00
View
Action Products, Inc.
Cynthia A. Harris
Price:
$117.00
View
Visionary Optics, LLC
Cynthia A. Harris
Price:
$117.00
View
Hemagen Diagnostic, Inc.
Cynthia A. Harris
Price:
$117.00
View
Futrex Incorporated
Cynthia A. Harris
Price:
$117.00
View
NovaSom, Inc.
Cynthia A. Harris
Price:
$117.00
View
Everest Spine, LLC
Cynthia A. Harris
Price:
$117.00
View
View All Products by Cynthia A. Harris
Upcoming Events
14
Jul
EU-MDR Postmarket Surveillance: Best Practices for Medical Device Regulatory, Compliance & Quality Specialists
15
Jul
Predictive Compliance Risk and Quality Management: A New Digital Paradigm for the Post-COVID-19 World
15
Jul
How to Address Medical Device Sample Size Issues: What Regulatory and Quality Professionals Absolutely Must Know
16
Jul
Micro-learning, Macro-Compliance: Improving GxP Compliance with Modern Learning Techniques
16
Jul
Inspection, Measuring and Test Equipment: A Regulatory Approach
22
Jul
Overcoming Comparability Issues in Regenerative Medicines Manufacturing: The Latest on Cell and Gene Therapy Regulation
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Gilead Sciences Kicks Off Phase 1 Trial of Inhaled Remdesivir for COVID-19
Nonin Medical’s Portable Measurement Device Cleared
New Data Shows Gilead’s Remdesivir Improves Recovery for COVID-19 Patients
FDA to Resume Domestic Inspections Using New Assessment System
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
